122 related articles for article (PubMed ID: 11107052)
1. Expression of cytokeratin 1, 5, 14, 19 and transforming growth factors-beta1, beta2, beta3 in osteofibrous dysplasia and adamantinoma: A possible association of transforming growth factor-beta with basal cell phenotype promotion.
Maki M; Saitoh K; Kaneko Y; Fukayama M; Morohoshi T
Pathol Int; 2000 Oct; 50(10):801-7. PubMed ID: 11107052
[TBL] [Abstract][Full Text] [Related]
2. Cytokeratin expression and distribution in adamantinoma of the long bones and osteofibrous dysplasia of tibia and fibula. An immunohistochemical study correlated to histogenesis.
Benassi MS; Campanacci L; Gamberi G; Ferrari C; Picci P; Sangiorgi L; Campanacci M
Histopathology; 1994 Jul; 25(1):71-6. PubMed ID: 7525449
[TBL] [Abstract][Full Text] [Related]
3. Osteofibrous dysplasia-like adamantinoma of bone: a report of five cases with immunohistochemical and ultrastructural studies.
Kuruvilla G; Steiner GC
Hum Pathol; 1998 Aug; 29(8):809-14. PubMed ID: 9712421
[TBL] [Abstract][Full Text] [Related]
4. [Classic adamantinoma, differentiated adamantinoma and osteofibrous dysplasia of long bones].
Povýsil C; Matĕjovský Z; Horák M
Cas Lek Cesk; 2004; 143(5):329-35. PubMed ID: 15305770
[TBL] [Abstract][Full Text] [Related]
5. Osteofibrous dysplasia and adamantinoma: correlation of proto-oncogene product and matrix protein expression.
Maki M; Athanasou N
Hum Pathol; 2004 Jan; 35(1):69-74. PubMed ID: 14745727
[TBL] [Abstract][Full Text] [Related]
6. Expression of transforming growth factor-beta (TGF-beta) isoforms in osteosarcomas: TGF-beta3 is related to disease progression.
Kloen P; Gebhardt MC; Perez-Atayde A; Rosenberg AE; Springfield DS; Gold LI; Mankin HJ
Cancer; 1997 Dec; 80(12):2230-9. PubMed ID: 9404699
[TBL] [Abstract][Full Text] [Related]
7. Cortical osteofibrous dysplasia of long bone and its relationship to adamantinoma. A clinicopathologic study of 30 cases.
Sweet DE; Vinh TN; Devaney K
Am J Surg Pathol; 1992 Mar; 16(3):282-90. PubMed ID: 1599019
[TBL] [Abstract][Full Text] [Related]
8. A clinicopathological and immunohistochemical study of osteofibrous dysplasia, differentiated adamantinoma, and adamantinoma of long bones.
Ishida T; Iijima T; Kikuchi F; Kitagawa T; Tanida T; Imamura T; Machinami R
Skeletal Radiol; 1992; 21(8):493-502. PubMed ID: 1281557
[TBL] [Abstract][Full Text] [Related]
9. Treatment of osteofibrous dysplasia and associated lesions.
Hahn SB; Kim SH; Cho NH; Choi CJ; Kim BS; Kang HJ
Yonsei Med J; 2007 Jun; 48(3):502-10. PubMed ID: 17594160
[TBL] [Abstract][Full Text] [Related]
10. Dedifferentiated classic adamantinoma of the tibia: a report of a case with eventual complete revertant mesenchymal phenotype.
Izquierdo FM; Ramos LR; Sánchez-Herráez S; Hernández T; de Alava E; Hazelbag HM
Am J Surg Pathol; 2010 Sep; 34(9):1388-92. PubMed ID: 20717000
[TBL] [Abstract][Full Text] [Related]
11. Juvenile intracortical adamantinoma of the tibia with predominant osteofibrous dysplasia-like features.
Ueda Y; Roessner A; Bosse A; Edel G; Böcker W; Wuisman P
Pathol Res Pract; 1991 Dec; 187(8):1039-43; discussion 1043-4. PubMed ID: 1724319
[TBL] [Abstract][Full Text] [Related]
12. Immunolocalization of TGF-beta1, -beta2, and -beta3, and TGF-beta receptors in human lens capsules with lens implants.
Saika S; Miyamoto T; Kawashima Y; Okada Y; Yamanaka O; Ohnishi Y; Ooshima A
Graefes Arch Clin Exp Ophthalmol; 2000 Mar; 238(3):283-93. PubMed ID: 10796043
[TBL] [Abstract][Full Text] [Related]
13. Podoplanin expression in adamantinoma of long bones and osteofibrous dysplasia.
Kashima TG; Dongre A; Flanagan AM; Hogendoorn PC; Taylor R; Athanasou NA
Virchows Arch; 2011 Jul; 459(1):41-6. PubMed ID: 21499851
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical localization of members of the transforming growth factor (TGF)-beta superfamily in normal human salivary glands and pleomorphic adenomas.
Kusafuka K; Yamaguchi A; Kayano T; Takemura T
J Oral Pathol Med; 2001 Aug; 30(7):413-20. PubMed ID: 11488419
[TBL] [Abstract][Full Text] [Related]
15. Congenital osteofibrous dysplasia of the tibia, associated with pseudoarthrosis of the ipsilateral fibula.
Zamzam MM
Saudi Med J; 2008 Oct; 29(10):1507-9. PubMed ID: 18946584
[TBL] [Abstract][Full Text] [Related]
16. Osteofibrous dysplasia of long bones--a reactive process to adamantinomatous tissue.
Ueda Y; Blasius S; Edel G; Wuisman P; Böcker W; Roessner A
J Cancer Res Clin Oncol; 1992; 118(2):152-6. PubMed ID: 1370955
[TBL] [Abstract][Full Text] [Related]
17. Adamantinoma of the long bones. A clinicopathological study of thirty-two patients with emphasis on histological subtype, precursor lesion, and biological behavior.
Hazelbag HM; Taminiau AH; Fleuren GJ; Hogendoorn PC
J Bone Joint Surg Am; 1994 Oct; 76(10):1482-99. PubMed ID: 7929496
[TBL] [Abstract][Full Text] [Related]
18. Morphologic diversity of long bone adamantinoma. The concept of differentiated (regressing) adamantinoma and its relationship to osteofibrous dysplasia.
Czerniak B; Rojas-Corona RR; Dorfman HD
Cancer; 1989 Dec; 64(11):2319-34. PubMed ID: 2804923
[TBL] [Abstract][Full Text] [Related]
19. Osteofibrous dysplasia: clinicopathologic study of 80 cases.
Park YK; Unni KK; McLeod RA; Pritchard DJ
Hum Pathol; 1993 Dec; 24(12):1339-47. PubMed ID: 8276381
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone.
Masi L; Malentacchi C; Campanacci D; Franchi A
Virchows Arch; 2002 May; 440(5):491-7. PubMed ID: 12021923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
